Alborelli, I.; Demes, M.; Wild, P.; Hernandez, S.; Lopez-Rios, F.; Bordone, O.; Bontoux, C.; Hofman, P.; De Luca, C.; Troncone, G.;
et al. ERBB2 Mutation Testing in NSCLC: A Pan-European Real-World Evaluation of the Oncomine Precision Assay. J. Mol. Pathol. 2025, 6, 19.
https://doi.org/10.3390/jmp6030019
AMA Style
Alborelli I, Demes M, Wild P, Hernandez S, Lopez-Rios F, Bordone O, Bontoux C, Hofman P, De Luca C, Troncone G,
et al. ERBB2 Mutation Testing in NSCLC: A Pan-European Real-World Evaluation of the Oncomine Precision Assay. Journal of Molecular Pathology. 2025; 6(3):19.
https://doi.org/10.3390/jmp6030019
Chicago/Turabian Style
Alborelli, Ilaria, Melanie Demes, Peter Wild, Susana Hernandez, Fernando Lopez-Rios, Olivier Bordone, Christophe Bontoux, Paul Hofman, Caterina De Luca, Giancarlo Troncone,
and et al. 2025. "ERBB2 Mutation Testing in NSCLC: A Pan-European Real-World Evaluation of the Oncomine Precision Assay" Journal of Molecular Pathology 6, no. 3: 19.
https://doi.org/10.3390/jmp6030019
APA Style
Alborelli, I., Demes, M., Wild, P., Hernandez, S., Lopez-Rios, F., Bordone, O., Bontoux, C., Hofman, P., De Luca, C., Troncone, G., Righi, L., Malapelle, U., Souza da Silva, R., Cirnes, L., Schmitt, F., Keller, E., Jermann, P. M., Longshore, J., & Bubendorf, L.
(2025). ERBB2 Mutation Testing in NSCLC: A Pan-European Real-World Evaluation of the Oncomine Precision Assay. Journal of Molecular Pathology, 6(3), 19.
https://doi.org/10.3390/jmp6030019
